Company / Financials
Boston Scientific Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$20.1B
FY2025 · +19.9% YoY
Net Income
$2.9B
FY2025 · +56.7% YoY
Profit Margin
14.4%
FY2025 · net income / revenue
ROE
11.9%
FY2025 · return on equity
Total Assets
$43.7B
FY2025
Total Debt
-
FY2025
Equity
$24.2B
FY2025
ROA
6.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$20.1B+19.9% YoYNet Income HistoryProfit after all expenses and taxes$2.9B+56.7% YoYGross Profit HistoryRevenue minus cost of goods sold$13.9B+20.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$6.2B+18.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes$3.6B+38.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$6.9B+15.1% YoYR&D Expense HistoryResearch and development spending$2.1B+27.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$349.0M+14.4% YoYIncome Tax HistoryTotal income tax expense$493.0M+13.1% YoYEPS (Basic) HistoryBasic earnings per share$1.96+55.6% YoY